Effects of protein kinase Cβ inhibition on neurovascular dysfunction in diabetic rats: Interaction with oxidative stress and essential fatty acid dysmetabolism

Diabetes/Metabolism Research and Reviews

Volumn 18, Issue 4, 2002, Pages 315-323

  Cameron, Norman E ^a,b   Cotter, Mary A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Blood flow; Diabetes; Essential fatty acid; Neuropathy; Oxidative stress; Protein kinase C; Rat

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ESSENTIAL FATTY ACID; GAMMA LINOLENIC ACID; OMEGA 6 FATTY ACID; PROTEIN KINASE C BETA; RUBOXISTAURIN; STREPTOZOCIN; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; FATTY ACID METABOLISM; HYDROGEN CLEARANCE; MALE; MICROELECTRODE; MOTOR NERVE CONDUCTION; NONHUMAN; OXIDATIVE STRESS; PERFUSION; POLAROGRAPHY; PRIORITY JOURNAL; RAT; SAPHENOUS NERVE; SCIATIC NERVE; SENSORY NERVE CONDUCTION; STREPTOZOCIN DIABETES;

ANIMALS; ANTIOXIDANTS; BLOOD FLOW VELOCITY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; ENZYME INHIBITORS; FATTY ACIDS, ESSENTIAL; INDOLES; MALE; MALEIMIDES; NEURAL CONDUCTION; OXIDATIVE STRESS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036657173     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.307     Document Type: Article

References (55)

1. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1-9.
2. Cameron NE, Eaton SEM, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001; 44: 1973-1988.
3. Sima AAF, Sugimoto K. Experimental diabetic neuropathy: an update. Diabetologia 1999; 42: 773-788.
4. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47: 859-866.
5. Greene DA, Sima AAF, Stevens MJ, Feldman EL, Lattimer SA. Complications: neuropathy, pathogenetic considerations. Diabetes Care 1992; 15: 1902-1925.
6. Jack AM, Cameron NE, Cotter MA. Effects of the diacylglycerol complexing agent, cremophor, on nerve conduction velocity and perfusion in diabetic rats. J Diabet Complications 1999; 13: 2-9.
7. +-ATPase activity and glutathione content in diabetic rats. Diabetologia 1999; 42: 1120-1130.
8. Nakamura J, Kato K, Hamada Y, et al. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Diabetes 1999; 48: 2090-2095.
9. 1 receptor antagonist. Am J Physiol 1995; 269: E530-E537.
10. Kihara M, Schmelzer JD, Low PA. Effect of cilostazol on experimental diabetic neuropathy in the rat. Diabetologia 1995; 38: 914-918.
11. Hotta N, Koh N, Sakakibara F, et al. Effects of beraprost sodium and insulin on the electroretinogram, nerve conduction and nerve blood flow in rats with streptozotocin-induced diabetes. Diabetes 1996; 45: 361-366.
12. Numaguchi K, Shimokawa H, Nakaike R, Egashira K, Takeshita A. PKC inhibitors prevent endothelial dysfunction after myocardial ischemia-reperfusion in rats. Am J Physiol 1996; 270: H1634-H1639.
13. Dines KC, Cotter MA, Cameron NE. Comparison of the effects of evening primrose oil and triglycerides containing gammalinolenic acid on nerve conduction and blood flow in diabetic rats. J Pharmacol Exp Ther 1995; 273: 49-55.
14. Cameron NE, Cotter MA, Hohman TC. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Diabetologia 1996; 39: 172-182.
15. Cameron NE, Cotter MA, Dines KC, Maxfield EK. Pharmacological manipulation of vascular endothelium in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Diabetologia 1993; 36: 516-522.
16. Cameron NE, Cotter MA, Horrobin DH, Tritschler HJ. Effects of α-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids. Diabetologia 1998; 41: 390-399.
17. Cotter MA, Love A, Watt MJ, Cameron NE, Dines KC. Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 1995; 38: 1285-1294.
18. Cameron NE, Cotter MA, Robertson S. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Q J Exp Physiol 1989; 74: 917-926.
19. Cameron NE, Cotter MA, Low PA. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 1991; 261: E1-E8.
20. Tuck RR, Schmelzer JD, Low PA. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 1984; 107: 935-950.
21. 2 clearance curves used to measure blood flow in rat sciatic nerve. J Physiol 1989; 414: 35-54.
22. Ways K, Bursell S, Devries T, et al. Amelioration of retinal hemodynamic dysfunction using a protein kinase C beta inhibitor in patients with diabetes. Diabetologia 1999; 42(Suppl. 1): A40.
23. Cameron NE, Cotter MA, Dines KC, Maxfield EK, Carey F, Mirrlees DJ. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism. Diabetologia 1994; 37: 651-663.
24. Nagamatsu M, Nickander KK, Schmelzer JD, et al. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995; 18: 1160-1167.
25. Cameron NE, Dines KC, Cotter MA. The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats. Diabetologia 1994; 37: 1209-1215.
26. Shimamoto Y, Shimamoto H, Kwan C, Daniel EE. Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle. Am J Physiol 1993; 264: H1300-H1306.
27. + currents in rat arterial smooth muscle through protein kinase C. J Physiol 1997; 503: 489-496.
28. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 1994; 46: 325-415.
29. Ohara Y, Sayegh HS, Yamin JJ, Harrison DG. Regulation of endothelial constitutive nitric oxide synthase by protein kinase C. Hypertension 1995; 25: 415-420.
30. Hirata K, Kuroda R, Sakoda T, et al. Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 1995; 25: 180-185.
31. Pelligrino, DA, Koenig HM, Wang Q, Albrecht RF. Protein kinase C suppresses receptor-mediated pial arteriolar relaxation in the diabetic rat. Neuroreport 1994; 5: 417-420.
32. Jack A, Cotter MA, Cameron NE. Treatment with the protein kinase Cβ inhibitor, LY333531, attenuates the development of impaired endothelium-dependent vasodilatation in the mesenteric vasculature of diabetic rats. Diabetes 1999; 48(Suppl. 1): A130.
33. Kihara M, Low PA. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp Neurol 1995; 132: 180-185.
34. Maxfield EK, Cameron NE, Cotter MA. Effects of diabetes on reactivity of sciatic vasa nervorum in rats. J Diabet Complications 1997; 11: 47-55.
35. Zhu X, Eichberg J. 1,2-Diacylglycerol content and its arachidonyl-containing molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats. J Neurochem 1990; 55: 1087-1090.
36. Kishi Y, Schmelzer JD, Yao JK, et al. α-Lipoic acid: effect on glucose uptake, sorbitol pathway and energy metabolism in experimental diabetic neuropathy. Diabetes 1999; 48: 2045-2051.
37. Roberts RE, McLean WG. Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats. Brain Res 1997; 754: 147-156.
38. Cameron NE, Cotter MA. Interaction between oxidative stress and γ-linolenic acid in impaired neurovascular function of diabetic rats. Am J Physiol 1996; 261: E471-E476.
39. Cameron NE, Cotter MA. Comparison of the effects of ascorbyl γ-linolenic acid and γ-linolenic acid in the correction of neurovascular deficits in diabetic rats. Diabetologia 1996; 39: 1047-1054.
40. Botting R, Vane JR. Mediators and anti-thrombotic properties of the vascular endothelium. Ann Med 1989; 21: 31-38.
41. Jack A, Cotter MA, Cameron NE. Essential fatty acid and diabetes effects on endothelium dependent relaxation in the rat mesenteric vasculature. Diabetologia 2000; 43(Suppl. 1): A69.
42. Rösen P, Ballhausen T, Bloch W, Addicks K. Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia 1995; 38: 1157-1168.
43. Archibald V, Cotter MA, Keegan A, Cameron NE. Contraction and relaxation of aortas from diabetic rats: effects of chronic anti-oxidant and aminoguanidine treatments. Naunyn Schmiedebergs Arch Pharmacol 1996; 353: 584-591.
44. Keegan A, Cotter MA, Cameron NE. Effects of diabetes and treatment with the antioxidant, α-lipoic acid, on endothelial and neurogenic functions of corpus cavernosum in rats. Diabetologia 1999; 42: 343-350.
45. Pieper GM, Langenstroer P, Siebeneich W. Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res 1997; 34: 145-156.
46. Cameron NE, Cotter MA. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 1992; 35: 1011-1019.
47. Kamata K, Chikada S, Umeda F, Kasuya Y. Effects of phorbol ester on vasodilation induced by endothelium-dependent or endothelium-independent vasodilators in the mesenteric arterial bed. J Cardiovasc Pharmacol 1995; 26: 645-652.
48. Rao KVR, Vaidyanathan VV, Sastry PS. Diacylglycerol kinase is stimulated by arachidonic acid in neural membranes. J Neurochem 1994; 63: 1454-1459.
49. Cho Y, Ziboh VA. 13-Hydroxyoctadecadienoic acid reverses epidermal hyperproliferation via selective inhibition of protein kinase C-β activity. Biochem Biophys Res Commun 1994; 201: 257-265.
50. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
51. Nickander KK, McPhee BR, Low PA, Tritschler H. Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Radic Biol Med 1996; 21: 631-639.
52. Nickander KK, Schmelzer JD, Rohwer DA, Low PA. Effects of α-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve. J Neurol Sci 1994; 126: 6-14.
53. van Dam PS, Bravenboer B, van Asbeck BS, Marx JJ, Gispen WH. High rat food vitamin E content improves nerve function in streptozotocin-diabetic rats. Eur J Pharmacol 1999; 376: 217-222.
54. Kunusaki M, Umeda F, Inoguchi T, Nawata H. Vitamin E restores reduced prostacyclin synthesis in aortic endothelial cells cultured with a high concentration of glucose. Metabolism 1992; 41: 613-621.
55. Kagokawa H, Clermont A, Bursell S. Differential effects of vitamin E and lipoic acid in retinal blood flow in diabetic rats. Diabetes 1999; 48(Suppl. 1): A153.